Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Intensive Care Units, Pediatric | 7 | 2021 | 1098 | 1.63 | Why? |
| Molybdenum | 2 | 2018 | 43 | 1.44 | Why? |
| Electrochemical Techniques | 5 | 2019 | 406 | 1.43 | Why? |
| Biosensing Techniques | 7 | 2019 | 2116 | 1.42 | Why? |
| Disulfides | 2 | 2018 | 161 | 1.34 | Why? |
| Nanostructures | 4 | 2019 | 700 | 1.31 | Why? |
| Acute Kidney Injury | 7 | 2020 | 5762 | 1.07 | Why? |
| Perfume | 1 | 2018 | 10 | 0.76 | Why? |
| Parathion | 1 | 2017 | 2 | 0.70 | Why? |
| Printing | 1 | 2017 | 4 | 0.70 | Why? |
| DNA, Single-Stranded | 1 | 2018 | 95 | 0.69 | Why? |
| Excipients | 1 | 2018 | 118 | 0.68 | Why? |
| Epoprostenol | 1 | 2017 | 41 | 0.66 | Why? |
| Prostate-Specific Antigen | 1 | 2018 | 213 | 0.66 | Why? |
| Fluid Therapy | 2 | 2020 | 628 | 0.65 | Why? |
| Antibodies, Immobilized | 1 | 2017 | 102 | 0.65 | Why? |
| Polymers | 2 | 2018 | 507 | 0.64 | Why? |
| Liver Failure, Acute | 2 | 2017 | 279 | 0.64 | Why? |
| Drug Compounding | 1 | 2018 | 386 | 0.61 | Why? |
| Quantum Dots | 1 | 2017 | 129 | 0.60 | Why? |
| Insecticides | 1 | 2017 | 178 | 0.58 | Why? |
| Aptamers, Nucleotide | 1 | 2018 | 265 | 0.55 | Why? |
| Graphite | 1 | 2017 | 318 | 0.50 | Why? |
| Nanotechnology | 1 | 2019 | 821 | 0.48 | Why? |
| Drug Carriers | 1 | 2018 | 590 | 0.47 | Why? |
| Renal Replacement Therapy | 2 | 2020 | 1530 | 0.45 | Why? |
| Antibodies | 1 | 2018 | 846 | 0.45 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.36 | Why? |
| Child | 20 | 2021 | 70012 | 0.30 | Why? |
| Critical Care | 5 | 2021 | 14081 | 0.29 | Why? |
| Pediatrics | 1 | 2021 | 2969 | 0.29 | Why? |
| Systemic Inflammatory Response Syndrome | 4 | 2021 | 6653 | 0.28 | Why? |
| Renal Dialysis | 2 | 2017 | 4358 | 0.25 | Why? |
| London | 2 | 2021 | 2166 | 0.23 | Why? |
| Prostaglandins I | 1 | 2020 | 4 | 0.22 | Why? |
| Porosity | 2 | 2018 | 185 | 0.22 | Why? |
| Hemodynamics | 2 | 2020 | 1562 | 0.21 | Why? |
| Citrates | 1 | 2020 | 37 | 0.21 | Why? |
| Anticoagulants | 2 | 2020 | 9563 | 0.19 | Why? |
| Nephrologists | 1 | 2020 | 117 | 0.19 | Why? |
| Aromatherapy | 1 | 2018 | 11 | 0.19 | Why? |
| Capsules | 1 | 2018 | 140 | 0.18 | Why? |
| Attention | 1 | 2020 | 335 | 0.17 | Why? |
| Spectrometry, Fluorescence | 1 | 2018 | 177 | 0.17 | Why? |
| Cosmetics | 1 | 2018 | 100 | 0.17 | Why? |
| Child, Hospitalized | 1 | 2020 | 556 | 0.16 | Why? |
| Arsenic | 1 | 2017 | 85 | 0.16 | Why? |
| Odorants | 1 | 2018 | 219 | 0.16 | Why? |
| Antipyretics | 1 | 2017 | 107 | 0.16 | Why? |
| Biocompatible Materials | 1 | 2018 | 214 | 0.15 | Why? |
| Health Plan Implementation | 1 | 2021 | 571 | 0.15 | Why? |
| Bacteriophages | 1 | 2017 | 268 | 0.14 | Why? |
| Peritoneal Dialysis | 1 | 2020 | 498 | 0.14 | Why? |
| Acetaminophen | 1 | 2017 | 326 | 0.13 | Why? |
| Nephrology | 1 | 2020 | 546 | 0.13 | Why? |
| Graft Survival | 1 | 2017 | 587 | 0.13 | Why? |
| Remote Sensing Technology | 1 | 2018 | 351 | 0.13 | Why? |
| Allografts | 1 | 2017 | 761 | 0.13 | Why? |
| DNA | 1 | 2019 | 778 | 0.13 | Why? |
| Textiles | 1 | 2018 | 458 | 0.13 | Why? |
| United Kingdom | 4 | 2021 | 18046 | 0.13 | Why? |
| Developed Countries | 1 | 2017 | 500 | 0.12 | Why? |
| Brain Injuries, Traumatic | 1 | 2018 | 381 | 0.12 | Why? |
| Tertiary Care Centers | 2 | 2021 | 8248 | 0.12 | Why? |
| New York | 1 | 2021 | 2488 | 0.12 | Why? |
| Humans | 28 | 2021 | 930598 | 0.12 | Why? |
| Luminescent Measurements | 1 | 2018 | 924 | 0.12 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.12 | Why? |
| Ecosystem | 1 | 2017 | 776 | 0.11 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.11 | Why? |
| Water Pollutants, Chemical | 1 | 2017 | 410 | 0.11 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.11 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.10 | Why? |
| Disinfection | 2 | 2021 | 2912 | 0.10 | Why? |
| Meta-Analysis as Topic | 1 | 2017 | 1289 | 0.10 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.10 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.09 | Why? |
| Resource Allocation | 1 | 2020 | 1771 | 0.09 | Why? |
| Drug Monitoring | 1 | 2017 | 1408 | 0.09 | Why? |
| Limit of Detection | 1 | 2017 | 2698 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.09 | Why? |
| Ventilators, Negative-Pressure | 1 | 2007 | 22 | 0.09 | Why? |
| Body Mass Index | 1 | 2020 | 4306 | 0.08 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.08 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.08 | Why? |
| Equipment Design | 1 | 2018 | 3095 | 0.08 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.08 | Why? |
| Education, Medical, Graduate | 1 | 2021 | 2082 | 0.08 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.08 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.08 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.08 | Why? |
| Respiratory Insufficiency | 1 | 2007 | 7301 | 0.07 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Nanoparticles | 1 | 2017 | 2040 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Animals | 3 | 2019 | 78931 | 0.07 | Why? |
| Blood Coagulation | 1 | 2017 | 2768 | 0.06 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
| Bronchiolitis | 1 | 2007 | 297 | 0.06 | Why? |
| Liver | 1 | 2017 | 4007 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Ventilator Weaning | 1 | 2007 | 536 | 0.06 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.05 | Why? |
| Developing Countries | 1 | 2017 | 4283 | 0.05 | Why? |
| Liver Transplantation | 1 | 2017 | 2864 | 0.05 | Why? |
| Infant | 2 | 2021 | 30274 | 0.05 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.05 | Why? |
| Adult | 4 | 2021 | 244371 | 0.05 | Why? |
| Fever | 1 | 2017 | 7795 | 0.05 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.05 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.05 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.05 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.04 | Why? |
| Intensive Care, Neonatal | 1 | 2021 | 284 | 0.04 | Why? |
| Wound Closure Techniques | 1 | 2017 | 18 | 0.04 | Why? |
| Comparative Effectiveness Research | 1 | 2018 | 178 | 0.04 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.04 | Why? |
| Surface Properties | 1 | 2018 | 448 | 0.04 | Why? |
| Membranes, Artificial | 1 | 2018 | 175 | 0.04 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.04 | Why? |
| Organ Size | 1 | 2017 | 384 | 0.04 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
| Spectrum Analysis, Raman | 1 | 2018 | 311 | 0.04 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.03 | Why? |
| Abdomen | 1 | 2017 | 424 | 0.03 | Why? |
| Male | 6 | 2020 | 367725 | 0.03 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.03 | Why? |
| Gold | 1 | 2017 | 592 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Ultraviolet Rays | 1 | 2021 | 1272 | 0.03 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
| Ireland | 1 | 2017 | 1456 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Body Weight | 1 | 2017 | 1074 | 0.03 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.03 | Why? |
| Metal Nanoparticles | 1 | 2017 | 771 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2021 | 2705 | 0.02 | Why? |
| England | 1 | 2021 | 5116 | 0.02 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Female | 5 | 2020 | 380317 | 0.02 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.02 | Why? |
| Forecasting | 1 | 2021 | 4492 | 0.02 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.02 | Why? |
| Middle Aged | 1 | 2021 | 270681 | 0.01 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.01 | Why? |
| Intensive Care Units | 1 | 2007 | 29594 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.01 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Risk Factors | 1 | 2017 | 71621 | 0.01 | Why? |
Deep's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(159)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(92)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_